JPH0134218B2 - - Google Patents
Info
- Publication number
- JPH0134218B2 JPH0134218B2 JP7813481A JP7813481A JPH0134218B2 JP H0134218 B2 JPH0134218 B2 JP H0134218B2 JP 7813481 A JP7813481 A JP 7813481A JP 7813481 A JP7813481 A JP 7813481A JP H0134218 B2 JPH0134218 B2 JP H0134218B2
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- carboxylic acid
- exchange resin
- ion exchange
- aziridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- -1 3-substituted aziridine-2-carboxylic acid Chemical class 0.000 claims description 26
- 230000002378 acidificating effect Effects 0.000 claims description 15
- 239000003729 cation exchange resin Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 description 23
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 17
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 17
- 239000004473 Threonine Substances 0.000 description 17
- 239000003456 ion exchange resin Substances 0.000 description 17
- 229920003303 ion-exchange polymer Polymers 0.000 description 17
- 239000007864 aqueous solution Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000002994 raw material Substances 0.000 description 13
- 239000012153 distilled water Substances 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- CXIYBDIJKQJUMN-QMMMGPOBSA-N (2s)-2-anilino-3-hydroxypropanoic acid Chemical compound OC[C@@H](C(O)=O)NC1=CC=CC=C1 CXIYBDIJKQJUMN-QMMMGPOBSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000005342 ion exchange Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- LDRFQSZFVGJGGP-GSVOUGTGSA-N 3-hydroxy-L-valine Chemical compound CC(C)(O)[C@H](N)C(O)=O LDRFQSZFVGJGGP-GSVOUGTGSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YDMOQLWVHXRFNI-LURJTMIESA-N (2s)-3-hydroxy-2-(pyridin-2-ylamino)propanoic acid Chemical compound OC[C@@H](C(O)=O)NC1=CC=CC=N1 YDMOQLWVHXRFNI-LURJTMIESA-N 0.000 description 2
- LQNRQHXPYZSWHH-UHFFFAOYSA-N 3,3-dimethylaziridine-2-carboxylic acid Chemical compound CC1(C)NC1C(O)=O LQNRQHXPYZSWHH-UHFFFAOYSA-N 0.000 description 2
- GMYKYCKUEYTTFJ-UHFFFAOYSA-N 3-methylaziridine-2-carbonitrile Chemical compound CC1NC1C#N GMYKYCKUEYTTFJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 2
- WBGBOXYJYPVLQJ-UHFFFAOYSA-N aziridine-2-carboxylic acid Chemical class OC(=O)C1CN1 WBGBOXYJYPVLQJ-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940023913 cation exchange resins Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- BKCZTUQBOINMEQ-UHFFFAOYSA-N propan-2-yl 3-methylaziridine-2-carboxylate Chemical compound CC(C)OC(=O)C1NC1C BKCZTUQBOINMEQ-UHFFFAOYSA-N 0.000 description 2
- IPVXDACNYLWMMK-UHFFFAOYSA-N propan-2-yl 3-phenylaziridine-2-carboxylate Chemical compound CC(C)OC(=O)C1NC1C1=CC=CC=C1 IPVXDACNYLWMMK-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LYBVTBCJUPMLBJ-HNNXBMFYSA-N (2s)-2-(n-benzylanilino)-3-hydroxypropanoic acid Chemical compound C=1C=CC=CC=1N([C@@H](CO)C(O)=O)CC1=CC=CC=C1 LYBVTBCJUPMLBJ-HNNXBMFYSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QOISFPILRGBKKL-UHFFFAOYSA-N 3-methylaziridine-2-carboxylic acid Chemical compound CC1NC1C(O)=O QOISFPILRGBKKL-UHFFFAOYSA-N 0.000 description 1
- GPBCRRMRLBDOKI-UHFFFAOYSA-N 3-phenylaziridine-2-carboxamide Chemical compound NC(=O)C1NC1C1=CC=CC=C1 GPBCRRMRLBDOKI-UHFFFAOYSA-N 0.000 description 1
- DUZMKNIYALAIRZ-UHFFFAOYSA-N 5-ethoxy-5h-benzo[7]annulene Chemical compound CCOC1C=CC=CC2=CC=CC=C12 DUZMKNIYALAIRZ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical group O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- CWCDZAMGWWARQB-UHFFFAOYSA-N ethyl 3-methylaziridine-2-carboxylate Chemical compound CCOC(=O)C1NC1C CWCDZAMGWWARQB-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- LDRYRACKTAWHCZ-UHFFFAOYSA-N methyl 3-methylaziridine-2-carboxylate Chemical compound COC(=O)C1NC1C LDRYRACKTAWHCZ-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- UZSOCTFIMNSUAG-UHFFFAOYSA-N propan-2-yl 3-pyridin-2-ylaziridine-2-carboxylate Chemical compound CC(C)OC(=O)C1NC1C1=CC=CC=N1 UZSOCTFIMNSUAG-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãβâããããã·ã¢ããé
žã®æ°èŠãªè£œ
é æ³ã«é¢ãããã®ã§ãããããã«è©³ããã¯ãïŒâ
眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãŸãã¯ãã®èªå°
äœã匷é
žæ§åã«ããªã³äº€ææš¹èã«åžçãããŠãæ°Ž
ã®ååšäžã«å ç±ããŠÎ²â眮æâβâããããã·ã¢
ããé
žã補é ããæ¹æ³ã«é¢ãããã®ã§ããã
βâ眮æâβâããããã·ã¢ããé
žãšããŠã¯ã
ããšãã°ãã¹ã¬ãªãã³ãããšãã«ã»ãªã³ãŸãã¯Î²
âããããã·ããªã³çãæãããããã¹ã¬ãªãã³
ã¯å¿
é ã¢ããé
žã®äžçš®ã§ããã飌ææ·»å å€ãšããŠ
ãã®å°æ¥æ§ãæåŸ
ãããããšãã«ã»ãªã³ãβâã
ãããã·ããªã³ãã¯ãããšããβâ眮æâβâã
ãããã·ã¢ããé
žã¯ãããèªèº«ã«çç掻æ§ãæåŸ
ããããšãšãã«ãçš®ã
ã®èŸ²å»è¬åã®äžéäœãšããŠ
ãæçšãªååç©ã§ããã
åŸæ¥ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã
ãã³ãã®èªå°äœããβâ眮æâβâããããã·ã¢
ããé
žã補é ããæ¹æ³ã«ã€ããŠã¯ãïŒâã¡ãã«ã¢
ãžãªãžã³âïŒâã«ã«ãã³é
žã¡ãã«ãšã¹ãã«ããã³
ãšãã«ãšã¹ãã«ã®æ··åç©ãéå¡©çŽ é
žã§åŠçãã
åŸãããã«ãå¡©é
žã§åŠçããŠã¹ã¬ãªãã³ã補é ã
ãæ¹æ³ïŒç¹éæ54â157555å·ïŒããŸããïŒâãã³
ãžã«âïŒâããšãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
ž
ã¡ãã«ãéå¡©çŽ é
žã§éç°å æ°Žå解ããã®ã¡ã
PdïŒïŒ£è§Šåªäžã«éå
ããããšã«ããããšãã«ã»
ãªã³ã補é ããæ¹æ³ãç¥ãããŠãã
ïŒHeterocyclesïŒïŒïŒ473ïŒ1978ïŒïŒãããããªã
ããåè
ã®æ¹æ³ã§ã¯ãçæããã¹ã¬ãªãã³ãå«ã
溶液ããã¹ã¬ãªãã³ãåé¢ããã«ã¯ãåå¿æ¶²ãæ¿
çž®ãã¢ã³ã¢ãã¢æ°Žã§PH調æŽåŸãã€ãªã³äº€ææš¹èã«
ãã粟補ããå¿
èŠããããå·¥çšãéåžžã«ç
©éã«ãª
ããšããæ¬ ç¹ãããããŸããåŸè
ã®æ¹æ³ã§ã¯ãé
å¡©çŽ é
žåŠçåŸãâãã³ãžã«ããšãã«ã»ãªã³ãå
é¢ããããã«PdïŒïŒ£è§Šåªäžã«éå
ããŠããã³ãž
ã«åºãã¯ããå¿
èŠããããããå·¥çšãéåžžã«ç
©é
ã«ãªããå·¥æ¥çã«ã¯æçšãªæ¹æ³ã§ã¯ãªãããŸãã
ïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãŸãã¯ãã®
èªå°äœã®éç°åå¿ã«ãããŠã¯ãåå¿ç³»ã«æ°Žããé«
ãæ±æ žèœãæããé°ã€ãªã³ãäŸãã°ãããã²ã³ã€
ãªã³ãå
±åãããšå¯çæç©ãšããŠããããã®ã€ãª
ã³ãä»å ããååç©ãçæããŠÎ²â眮æâβâã
ãããã·ã¢ããé
žã®åçãäœäžãããæ¬ ç¹ãæã
ãããã®ããã«ãβâ眮æâβâããããã·ã¢ã
ãé
žã®è£œæ³ãšããŠãããã€ãã®æ¹æ³ãææ¡ãããŠ
ããããããããäžé·äžçããããå·¥æ¥çã«æºè¶³
ããã補é æ³ã¯èŠåœããªãã
æ¬çºæè
ãã¯ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«
ãã³é
žãŸãã¯ãã®èªå°äœããβâ眮æâβâãã
ããã·ã¢ããé
žã®å·¥æ¥ç補é æ³ãéææ€èšããçµ
æãæ¬çºæã®æ¹æ³ã«å°éããã
ããªãã¡ãæ¬çºæã¯ãäžè¬åŒïŒïŒ
ïŒåŒäžãR1ã¯ã¡ãã«åºã眮æãããã¯ç¡çœ®æ
ã®ããšãã«åºãŸãã¯ããªãžã«åºãR2ã¯æ°ŽçŽ åå
ãŸãã¯ã¡ãã«åºã瀺ããã¯âCO2HãâCO2M
ïŒããã§ãïŒã¯ã¢ã«ã«ãªéå±ãŸãã¯ã¢ã«ã«ãªåé¡
éå±ã§ããïŒãâCO2R3ïŒããã§ãR3ã¯ççŽ åå
æ°ïŒãïŒã®äœçŽã¢ã«ãã«åºãŸãã¯ãã³ãžã«åºã§ã
ãïŒãâCO2NH2ãŸãã¯âCNã瀺ãïŒã§è¡šãã
ããïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãŸãã¯
ãã®èªå°äœã匷é
žæ§åã«ããªã³äº€ææš¹èã«åžçã
ããŠãæ°Žã®ååšäžã§å ç±ããŠÎ²â眮æâβâãã
ããã·ã¢ããé
žã補é ããæ¹æ³ã§ããã
ãã®ãããªæ¬çºæã®æ¹æ³ã¯ãåŸæ¥å
šãç¥ãããŠ
ããªãæ°èŠãªæ¹æ³ã§ãã€ãŠãåŸæ¥å
¬ç¥ã®æ¹æ³ã«ã
ãã¹ãŠå·¥çšãèããç°¡ç¥åãããã»ãšãã©å¯çç©
ã䌎ãããšããªããçžåœããβâããããã·ã¢ã
ãé
žãé«åçã§åŸãããå©ç¹ããããããã«ã¯ã
åå¿ã«ãã€ãŠçæããβâ眮æâβâããããã·
ã¢ããé
žã®åé¢ã¯ãå ç±åŸã®è©²ã€ãªã³äº€ææš¹èã«
ã¢ã³ã¢ãã¢æ°ŽãæµããŠÎ²â眮æâβâããããã·
ã¢ããé
žã溶é¢ãã溶é¢æ¶²ãæ¿çž®ä¹ŸåºãŸãã¯æ¿çž®
æ¶æããã ãã®ç°¡åãªæäœã§å¯èœã§ããããã®ã
ãã«åå¿ã粟補ããã³åé¢ãåæã«è¡ããããšã
æ¬çºæã®æ¹æ³ã®å€§ããªç¹åŸŽã®ïŒã€ã§ããã
æ¬çºæã®æ¹æ³ã§äœ¿çšãããåæã¯ãåèšäžè¬åŒ
ïŒïŒã§è¡šããããïŒâ眮æã¢ãžãªãžã³âïŒâã«
ã«ãã³é
žãŸãã¯ãã®èªå°äœã§ããããããã®åæ
ååç©ã¯ãβâ眮æâαïŒÎ²âãžããã²ãããã
ãªã³é
žãŸãã¯ãã®èªå°äœãŸãã¯Î²â眮æâαâã
ãã²ãã¢ã¯ãªã«é
žèªå°äœãšã¢ã³ã¢ãã¢ãšã®åå¿
ïŒç¹éæ54â157555å·ïŒE.KyburzïŒHelv.Chim.
actaïŒ49ïŒ359ïŒ1966ïŒïŒG.SzeimiesïŒChem.Ber.ïŒ
110ïŒ1792ïŒ1977ïŒïŒE.P.StyhgachïŒKhim.
Geterotsikl.SoedinïŒ1973ïŒ1523ïŒY.YukawaïŒ
Mem.Inst.Sci.and Ind.ResearchïŒOsaka
Univ.ïŒ14ïŒ191ïŒ1957ïŒïŒE.P.StyngackïŒIzv.
Akad.Nauk.Mold.SSR.Ser.Biol.Khim.NankïŒ
1975ïŒ62ïŒããããã¯ãïŒâ眮æã¢ã¯ãªã«é
žãšã¹
ãã«ãšã¢ãžãã«ã«ãã³é
žãšã¹ãã«ã®ç±å解åå¿ã
ïŒM.P.SamnesïŒJ.Chem.Soc.ïŒPerkin Trans.1ïŒ
1972ïŒ344ïŒãããã«ã¯ãïŒâ眮æã¢ãžãªãžã³âïŒ
âã«ã«ãã³é
žã®ã¢ã«ã«ãªéå±ãŸãã¯ã¢ã«ã«ãªåé¡
éå±å¡©ã¯ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
ž
ãšã¹ãã«ãçéã®ã¢ã«ã«ãªéå±ãŸãã¯ã¢ã«ã«ãªå
é¡éå±ã®æ°Žé
žåç©ã§åŠçãããããããã¯ãβâ
眮æâαâã¢ããâβâããã²ãããããªã³é
žã
ããã¯ãã®èªå°äœïŒãšã¹ãã«ãã¢ããããããª
ã«ïŒãŸãã¯Î²â眮æâαâããã²ãâβâã¢ãã
ããããªã³é
žãããã¯ãã®èªå°äœããã¢ã«ã«ãªé
å±ãŸãã¯ã¢ã«ã«ãªåé¡éå±ã®æ°Žé
žåç©ã§åŠçãã
çã®å
¬ç¥æè¡ããããã¯ããã«æºããæ¹æ³ã«ãã
補é ã§ããã
æ¬çºæã®æ¹æ³ã§äœ¿çšãã匷é
žæ§åã«ããªã³äº€æ
æš¹èã¯ãåãNaåãNH+ 4åçãããã®åã§ã
ããããéåžžãåã䜿çšããããšã奜ãŸããã
ãŸãã€ãªã³äº€ææš¹èã®åºäœã¯ãã²ã«åãããŒã©ã¹
åãŸãã¯ãã¯ãããŒã©ã¹åçã®ããããåºäœã®ã
ã®ã䜿çšããããšãã§ããããããã€ãŠåŒ·é
žæ§å
ã«ããªã³äº€ææš¹èã§ããã°ããã®éæã¯ç¹ã«éå®
ããããã®ã§ã¯ãªãããŸããïŒéæ以äžã®åŒ·é
žæ§
åã«ããªã³äº€ææš¹èã䜵çšããããšãäœãå·®ãæ¯
ããªããã€ãªã³äº€ææš¹èã®äœ¿çšéã¯ãåæãšããŠ
ïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã®ã¢ã«ã«ãª
éå±ãŸãã¯ã¢ã«ã«ãªåé¡éå±å¡©ã䜿çšããå Žåã¯
ïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãšããããš
å¡©ããªããŠããéå±ã€ãªã³ã®ç·éã«å¯ŸããŠã湿最
ç¶æ
ã§ã®äº€æ容éã§ïŒåœé以äžã奜ãŸããã¯ã
1.2åœé以äžã§ãããäŸãã°ãïŒã¢ã«ã®ïŒâ眮æ
ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã«ãªãŠã å¡©ãåæãš
ããç·äº€æ容éãïŒåœéïŒã®åŒ·é
žæ§åã«ããªã³
亀ææš¹èã䜿çšããå Žåããã®æš¹è䜿çšéã¯ãïŒ
以äžå¥œãŸããã¯1.2以äžã§ããããŸããïŒâ
眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žããŸãã¯ãã®ãš
ã¹ãã«ãã¢ããããããªã«çã®èªå°äœãçšããå Ž
åã¯ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãŸã
ã¯ãã®èªå°äœãã®ãã®ã«å¯ŸããŠã湿最ç¶æ
ã§ã®äº€
æ容éã§ïŒåœé以äžã奜ãŸããã¯ã1.2åœé以äž
ã§ãããäŸãã°ïŒã¢ã«ã®ïŒâ眮æã¢ãžãªãžã³âïŒ
âã«ã«ãã³é
žãšãã«ãšã¹ãã«ãåæãšããç·äº€æ
容éãïŒåœéïŒã®åŒ·é
žæ§åã«ããªã³äº€ææš¹èã
䜿çšããå Žåãã®æš¹è䜿çšéã¯ã0.5以äžã奜
ãŸããã¯0.6以äžã§ãããåæã®æ°Žæº¶æ¶²äžã«å¡©
åãããªãŠã ãèåã¢ã³ã¢ããŠã çã®ç¡æ©å¡©ãã
ã¢ããåºãå«ãã ååç©ã®ããã«åŒ·é
žæ§åã«ããª
ã³äº€ææš¹èã«åžçãããããç©è³ªãå«ãŸããå Ž
åããããã®ç©è³ªã«çžåœããå以äžã«æš¹èéãå¢
éããŠããå¿
èŠãããã
æ¬çºæã®æ¹æ³ã§ã¯ãåèšäžè¬åŒïŒïŒã§è¡šãã
ããïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãŸãã¯
ãã®èªå°äœã¯ã氎溶液ãŸãã¯æ°Žãšæ··åæ§ã®ææ©æº¶
åªãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœããã
ããŒã«çã®ã¢ã«ã³ãŒã«é¡ãå«æãã氎溶液ãšãã
ããçã®æ°Žæº¶æ¶²ã匷é
žæ§åã«ããªã³äº€ææš¹èãå
å¡«ããæš¹èå¡ã«æµããããã«æ°ŽæŽããæ¹æ³ããŸã
ã¯ãããã®æ°Žæº¶æ¶²ã«åŒ·é
žæ§åã«ããªã³äº€ææš¹èã
æ·»å æ··åããæ¹æ³ã«ãã€ãŠãã€ãªã³äº€ææš¹èã«åž
çãããããšãã«ãåæååç©ã®æ°Žæº¶æ¶²äžã«ãå¡©
åãããªãŠã ãèåã¢ã³ã¢ããŠã çã®ããã«ã€ãª
ã³äº€æã«ãã€ãŠå¡©é
žãèåæ°ŽçŽ é
žã®ãããªé
žçŽ ç©
質ãçæããååç©ãå«ãŸããå Žåã«ã¯ãåæå
åç©ãã€ãªã³äº€ææš¹èããè±é¢ããããããã²ã³
ã€ãªã³ãåæååç©ãšåå¿ããå¯èœæ§ãããã®
ã§ãåæ氎溶液ãã€ãªã³äº€ææš¹èå¡ã«æµãããã®
åŸååã«æ°ŽæŽããŠãïŒâ眮æã¢ãžãªãžã³âïŒâã«
ã«ãã³é
žãŸãã¯ãã®èªå°äœã匷é
žæ§åã«ããªã³äº€
ææš¹èã«åžçãããæ¹æ³ã奜ãŸããã
ãã®ããã«ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ã
ã³é
žãŸãã¯ãã®èªå°äœãåžçããã匷é
žæ§åã«ã
ãªã³äº€ææš¹èã¯ãæ°Žã®ååšäžã«å ç±ãããããã®
å ç±æ¹æ³ã«ã¯ãç¹ã«éå®ã¯ãªããã湿最ç¶æ
ãä¿
ã€å¿
èŠããããå ç±ãããæ°Žãã€ãªã³äº€ææš¹èã
å
å¡«ããå¡ã«é£ç¶çã«æµããŠãããããŸãã€ãªã³
亀ææš¹èãå
å¡«ããå¡ãå€éšããå ç±ããŠãã
ãããããã¯ãã€ãªã³äº€ææš¹èãå¥ã®å®¹åšã«ç§»
ããæ°Žã®ååšäžã«æ¹æããªããå ç±ããããšãã§
ããã
ãã®å ç±æ¡ä»¶ã¯ã40ã120âãïŒã100æéã奜
ãŸããã¯ã50ã100âãïŒã50æéã§ãããåå¿
ã¯40â以äžã®æž©åºŠãäŸãã°ã宀枩ã§ãé²è¡ãã
ããåå¿ã®å®çµã«èããé·æéãèŠãå®éçã§ã¯
ãªãã
ã€ãªã³äº€ææš¹èã«åžçç¶æ
ã®ïŒâ眮æã¢ãžãªãž
ã³âïŒâã«ã«ãã³é
žãŸãã¯èªå°äœãå ç±ããŠçæ
ããβâ眮æâβâããããã·ã¢ããé
žã¯ãåå¿
åŸã€ãªã³äº€ææš¹èã«åžçãããç¶æ
ã«ããããã®
βâ眮æâβâããããã·ã¢ããé
žãåé¢ããã«
ã¯ãåžžæ³ã«ãããã€ãŠã€ãªã³äº€ææš¹èãã溶é¢ã
äŸãã°ãåžçãããŠããβâ眮æâβâãããã
ã·ã¢ããé
žãã¢ã³ã¢ãã¢æ°Žã§æº¶é¢ãããã®æº¶é¢æ¶²
ãæ¿çž®ä¹ŸåºãããããŸãã¯Î²â眮æâβâããã
ãã·ã¢ããé
žã®æº¶è§£åºŠä»¥äžã«æ¿çž®ããã®ã¡ãæ¶æ
ã«ãã€ãŠåé¢ããã
以äžãå®æœäŸã«ãã€ãŠæ¬çºæã®æ¹æ³ã説æã
ãããªããå®æœäŸïŒãïŒããã³10ïŒ11ã§çšããã
ãåæã®ïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
ž
å¡©ããŸãã¯ïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é
ž
èªå°äœã¯ãã·ã¹äœãšãã©ã³ã¹äœã®æ··åç©ã§ããã
åŸãããβâããããã·ã¢ããé
žãã¹ã¬ãªäœãšãš
ãªã¹ãäœã®æ··åç©ã§ããã
ãªããå®æœäŸã«ãããŠãçŽåºŠåæãªãã³ã«åç
ã¯ãé«é液äœã¯ãããã°ã©ãã€ãŒãæ žç£æ°å
±é³Žã¹
ãã¯ãã«çã®æ¹æ³ã«ãã€ãŠæ±ããã
å®æœäŸ ïŒ
ïŒâã¡ãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãšãã«
ãšã¹ãã«12.9ïœã®æ°Žæº¶æ¶²160mlã匷é
žæ§åã«ããª
ã³äº€ææš¹èLewatit â100ïŒïŒšåïŒïŒãã€ãšã«ç€Ÿ
補ïŒ60mlã«éããããã«èžçæ°Ž60mlã§æ°ŽæŽããŠïŒ
âã¡ãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãšãã«ãšã¹
ãã«ãåžçãããããã®åŸããã®ã€ãªã³äº€ææš¹è
ã100mlã®ãã©ã¹ã³ã«ç§»ãã80ã85âã§ïŒæéå
å¿ãããåŸãåã³ã«ã©ã ã«ç§»ãïŒïŒ
ã¢ã³ã¢ãã¢æ°Ž
90mlãšèžçæ°Ž60mlã§æº¶é¢ããããã®æº¶é¢æ¶²ãæ¿çž®
也åºããŠã¹ã¬ãªãã³11.4ïœãåŸããåŸãããã¹ã¬
ãªãã³ã¯ãçŽåºŠ92.5ïŒ
ã§ãåçã¯88.6ïŒ
ã§ãã€
ãã
ãŸããåæãšããŠãïŒâã¡ãã«ã¢ãžãªãžã³âïŒ
âã«ã«ãã³é
žãšãã«ãšã¹ãã«ã®ã·ã¹äœïŒãã©ã³ã¹
äœã66ïŒ34ã®æ··åç©ãçšããå Žåãçæããã¹ã¬
ãªãã³ã¯ã¹ã¬ãªäœïŒã¢ãäœã70ïŒ30ã®æ··åç©ã§ã
ã€ãã
ããã«ãåæãšããŠãã·ã¹äœã®ã¿ãçšããå Žå
ã»ãšãã©ã¹ã¬ãªäœã§ãã€ãã
å®æœäŸ ïŒ
ïŒâã¡ãã«ã¢ãžãªãžã³âïŒâãããªã«8.2ïœã®
氎溶液136mlãLewatit â100ïŒïŒšåïŒ60mlã«é
ããããã«èžçæ°Ž60mlã§æ°ŽæŽããŠãïŒâã¡ãã«ã¢
ãžãªãžã³âïŒâãããªã«ãåžçãããããã®åŸã
ã®ã€ãªã³äº€ææš¹èã«80ã85âã«å ç±ãããç±æ°Žã
ïŒæé埪ç°ããããåå¿åŸã€ãªã³äº€æã«ã©ã ãå·
åŽããïŒïŒ
ã¢ã³ã¢ãã¢æ°Ž90mlãšèžçæ°Ž60mlã§æº¶é¢
ãããã®æº¶é¢æ¶²ãæ¿çž®ä¹Ÿåºããã¹ã¬ãªãã³4.9ïœ
ãå«æããåºäœ7.6ïœãåŸããåŸãããã¹ã¬ãªã
ã³ã¯çŽåºŠ64.5ïŒ
ãåç41.2ïŒ
ã§ãã€ãã
å®æœäŸ ïŒ
αâã¯ããâβâã¢ããâïœâããããããªã«
å¡©é
žå¡©15.5ïœã®æ°Žæº¶æ¶²160ïœã«ãæ¹æäžãæ°Žé
žå
ãããªãŠã 12.8ïœã90ïœã®æ°Žã«æº¶è§£ãã氎溶液ã
é€ã
ã«æ»Žäžãããã€ãã§ãã®åå¿æ··åç©ã60âã«
ææž©ãã60ã65âã§ïŒæéåå¿ãããã
次ã«ãã®åå¿æ¶²ãå·åŽãïŒïŒ
ç¡«é
žæ°Žæº¶æ¶²ã§äžå
ããLewatit â100ïŒïŒšåïŒ400mlãå
å¡«ããã«
ã©ã ã«éãããããã«ã«ã©ã ããã®çåºæ¶²äžã«å¡©
çŽ ã€ãªã³ãæ€åºãããªããªããŸã§ãèžçæ°Žãæµã
ãããã®åŸããã®ïŒâã¡ãã«ã¢ãžãªãžã³âïŒâã«
ã«ãã³é
žãåžçããã€ãªã³äº€æã«ã©ã ã«85ã90â
ã«å ç±ãããç±æ°ŽãïŒæé埪ç°ããŠåå¿ãããã
åå¿åŸã€ãªã³äº€æã«ã©ã ãå·åŽããïŒïŒ
ã¢ã³ã¢ã
ã¢æ°Ž600mlãšãèžçæ°Ž400mlã«ãã€ãŠæº¶é¢ãããã
ã®æº¶é¢æ¶²ãæ¿çž®ä¹ŸåºããŠ11.0ïœã®ã¹ã¬ãªãã³ãåŸ
ããåŸãããã¹ã¬ãªãã³ã¯çŽåºŠ88.7ïŒ
ãåç82ïŒ
ã§ãã€ãã
å®æœäŸ ïŒ
αâã¯ããâβâã¢ããé
ªé
žãšãã«ãšã¹ãã«å¡©
é
žå¡©20.2ïœãçšããå€ã¯å®æœäŸïŒãšå
šãåæ§ã®å
å¿ãè¡ããã¹ã¬ãªãã³10.5ïœãåŸããåŸãããã¹
ã¬ãªãã³ã¯çŽåºŠ93.0ïŒ
ãåç82.0ïŒ
ã§ãã€ãã
å®æœäŸ ïŒ
ïŒâã¡ãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã€ãœã
ããã«ãšã¹ãã«7.2ïœã®æ°Žæº¶æ¶²100mlãLewatit 
â100ïŒïŒšåïŒ30mlã«éããããã«èžçæ°Ž30mlã§æ°Ž
æŽããŠãïŒâã¡ãã«âã¢ãžãªãžã³âïŒâã«ã«ãã³
é
žã€ãœãããã«ãšã¹ãã«ãåžçãããããã®åŸã
ãã®ã€ãªã³äº€ææš¹èã«80ã85âã«å ç±ããç±æ°Žã
ïŒæé埪ç°ããããåå¿åŸãã€ãªã³äº€æã«ã©ã ã
å·åŽããïŒïŒ
ã¢ã³ã¢ãã¢æ°Ž45mlãšèžçæ°Ž30mlã§æº¶
é¢ãããã®æº¶é¢æ¶²ãæ¿çž®ä¹Ÿåºãã¹ã¬ãªãã³11.2ïœ
ãåŸããåŸãããã¹ã¬ãªãã³ã¯çŽåºŠ95.9ïŒ
ãåç
90.3ïŒ
ã§ãã€ãã
å®æœäŸ ïŒãïŒ
匷é
žæ§åã«ããªã³äº€ææš¹èãLewatit â100
ã®ãããã«ä»ã®æš¹èãçšãããã®ä»ã¯å®æœäŸïŒãš
åæ§ã«åå¿ãè¡ããè¡šâïŒã«ç€ºãçµæãåŸãã
ãè¡šã
å®æœäŸ ïŒ
ïŒïŒïŒâãžã¡ãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
ž
5.8ïœã®æ°Žæº¶æ¶²72mlãLewatit â100ïŒïŒšåïŒ30
mlã«éããããã«èžçæ°Ž30mlã§æ°ŽæŽããŠïŒïŒïŒâ
ãžã¡ãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žãåžçãã
ãããã®åŸããã®ã€ãªã³äº€ææš¹èã100mlã®ãã©
ã¹ã³ã«ç§»ãã80ã85âã§ïŒæéåå¿ãããåŸãå
ã³ã«ã©ã ã«ç§»ãïŒïŒ
ã¢ã³ã¢ãã¢æ°Ž45mlãšèžçæ°Ž30
mlã§æº¶é¢ããããã®æº¶é¢æ¶²ãæ¿çž®ä¹ŸåºããŠÎ²âã
ãããã·ããªã³6.4ïœãåŸããåŸãããβâãã
ããã·ããªã³ã¯çŽåºŠ91.3ïŒ
ãåç88.5ïŒ
ã§ãã€
ãã
å®æœäŸ 10
ïŒâããšãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã€ãœ
ãããã«ãšã¹ãã«10.3ïœã溶解ãã氎溶液150ml
ãLewatit â100ïŒïŒšåïŒ40mlã«é©ããèžçæ°Ž
40mlã§æ°ŽæŽããŠïŒâããšãã«ã¢ãžãªãžã³âïŒâã«
ã«ãã³é
žã€ãœãããã«ãšã¹ãã«ãåžçããããã
ã®åŸããã®ã€ãªã³äº€ææš¹èã«80ã85âã«å ç±ãã
ç±æ°ŽãïŒæé埪ç°ããããåå¿åŸãã€ãªã³äº€æã«
ã©ã ãå·åŽããïŒïŒ
ã¢ã³ã¢ãã¢æ°Ž60mlãšèžçæ°Ž90
mlã§æº¶é¢ããã®æº¶é¢æ¶²ãæ¿çž®ä¹Ÿåºããçæç©9.0
ïœãåŸããçæç©ã¯83.3ïŒ
ã®ããšãã«ã»ãªã³ãå«
æããããšãã«ã»ãªã³ãšããŠã®åçã¯82.9ïŒ
ã§ã
ã€ãã
å®æœäŸ 11
ïŒâããšãã«ã¢ãžãªãžã³âïŒâã«ã«ãã³é
žã¢ã
ã8.1ïœã®æ°Žæº¶æ¶²160mlãå®æœäŸ10ãšå
šãåããã
ã«åŠçããŠãçæç©8.7ïœãåŸããçæç©ã¯56.3
ïŒ
ã®ããšãã«ã»ãªã³ãå«æããããšãã«ã»ãªã³ã®
åçã¯54.1ïŒ
ã§ãã€ãã
å®æœäŸ 12
ïŒâïŒïŒâããªãžã«ïŒã¢ãžãªãžã³âïŒâã«ã«ã
ã³é
žã€ãœãããã«ãšã¹ãã«10.3ïœã®æ°Žæº¶æ¶²160ml
ããå®æœäŸ10ãšåãããã«åŠçããŠãçæç©9.2
ïœãåŸããçæç©ã¯80.4ïŒ
ã®ïŒâããªãžã«ã»ãªã³
ãå«æããïŒâããªãžã«ã»ãªã³ã®åçã¯81.3ïŒ
ã§
ãã€ãã
å®æœäŸ 13
å®æœäŸïŒãšåãæ¹æ³ããã¢ãžãªãžã³âïŒâã«ã«
ãã³é
žã¡ãã«ãšã¹ãã«ã«ä»£ããŠãïŒâã¡ãã«ã¢ãž
ãªãžã³âïŒâã«ã«ãã³é
žãã³ãžã«ãšã¹ãã«19.1ïœ
ã䜿çšããŠå®æœããã
11.8ïœã®ã¹ã¬ãªãã³ãåŸããããçŽåºŠ91.7ïŒ
ã
åç91.3ïŒ
ã§ãã€ãã DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing β-hydroxyamino acids. For more details, see 3-
The present invention relates to a method for producing a β-substituted β-hydroxyamino acid by adsorbing substituted aziridine-2-carboxylic acid or a derivative thereof onto a strongly acidic cation exchange resin and heating it in the presence of water. As β-substituted-β-hydroxy amino acids,
For example, threonine, phenylserine or β
-Hydroxyvaline etc. Threonine is a type of essential amino acid and is expected to have potential as a feed additive, while β-substituted β-hydroxy amino acids such as phenylserine and β-hydroxyvaline are expected to have physiological activity on their own. It is also a useful compound as an intermediate for various agricultural medicines. Conventionally, in a method for producing β-substituted β-hydroxy amino acids from 3-substituted aziridine-2-carboxylic acid and its derivatives, a mixture of 3-methylaziridine-2-carboxylic acid methyl ester and ethyl ester was treated with perchloric acid. and then further treatment with hydrochloric acid to produce threonine. After ring hydrolysis,
A method for producing phenylserine by reduction under a Pd/C catalyst is known (Heterocycles, 9 , 473 (1978)). However, in the former method, in order to isolate threonine from the solution containing threonine produced, it is necessary to concentrate the reaction solution, adjust the pH with aqueous ammonia, and then purify it using an ion exchange resin, making the process extremely complicated. It has the disadvantage of becoming. In addition, in the latter method, it is necessary to isolate N-benzylphenylserine after treatment with perchloric acid, and then reduce it under a Pd/C catalyst to remove the benzyl group, making the process extremely complicated. , is not an industrially useful method. Also,
In the ring-opening reaction of 3-substituted aziridine-2-carboxylic acid or its derivatives, if anions with higher nucleophilic ability than water, such as halogen ions, coexist in the reaction system, these ions may be added as by-products. It also has the disadvantage that compounds are formed and the yield of β-substituted β-hydroxy amino acids is reduced. As described above, several methods have been proposed for producing β-substituted β-hydroxyamino acids, but each has advantages and disadvantages, and no industrially satisfactory production method has been found. The present inventors have intensively studied methods for industrially producing β-substituted β-hydroxy amino acids from 3-substituted aziridine-2-carboxylic acids or derivatives thereof, and as a result, have arrived at the method of the present invention. That is, the present invention provides the general formula () (In the formula, R 1 is a methyl group, a substituted or unsubstituted phenyl group, or a pyridyl group, R 2 is a hydrogen atom or a methyl group, and X is -CO 2 H, -CO 2 M
(Here, M is an alkali metal or alkaline earth metal), -CO 2 R 3 (Here, R 3 is a lower alkyl group having 1 to 5 carbon atoms or a benzyl group), -CO 3-Substituted aziridine-2-carboxylic acid or its derivatives represented by 2 NH 2 or -CN) is adsorbed onto a strongly acidic cation exchange resin and heated in the presence of water to form β-substituted -β- This is a method for producing hydroxyamino acids. The method of the present invention is a novel method that has not been previously known. Compared to conventionally known methods, the process is significantly simplified, almost no by-products are produced, and the corresponding β-hydroxy It has the advantage that amino acids can be obtained in high yield. Furthermore,
The β-substituted β-hydroxy amino acid produced by the reaction is isolated by flowing aqueous ammonia through the heated ion exchange resin to elute the β-substituted β-hydroxy amino acid, and concentrating the eluate to dryness. Alternatively, it can be performed by a simple operation of concentration and crystallization, and one of the major features of the method of the present invention is that reaction, purification, and isolation can be performed simultaneously in this way. The raw material used in the method of the present invention is a 3-substituted aziridine-2-carboxylic acid represented by the above general formula () or a derivative thereof, and these raw material compounds are β-substituted-α,β-dihalogenated Reaction of propionic acid or its derivatives or β-substituted-α-halogenoacrylic acid derivatives with ammonia (JP-A-54-157555; E. Kyburz, Helv. Chim.
acta, 49, 359 (1966); G. Szeimies, Chem. Ber.
110, 1792 (1977); EPStyhgach, Khim.
Geterotsikl. Soedin, 1973, 1523; Y. Yukawa,
Mem.Inst.Sci.and Ind.ResearchïŒOsaka
Univ., 14, 191 (1957); EPStyngack, Izv.
Akad.Nauk.Mold.SSR.Ser.Biol.Khim.Nank,
1975, 62), or thermal decomposition reaction of 3-substituted acrylic acid ester and azidocarboxylic acid ester,
(MPSamnes, J.Chem.Soc., Perkin Trans.1,
1972, 344), and furthermore, 3-substituted aziridine-2
-Alkali metal or alkaline earth metal salts of carboxylic acids can be prepared by treating a 3-substituted aziridine-2-carboxylic acid ester with an equal amount of alkali metal or alkaline earth metal hydroxide, or by treating β-
Substituted α-amino-β-halogenopropionic acid or its derivatives (esters, amides, nitriles) or β-substituted α-halogeno-β-aminopropionic acid or its derivatives by hydroxylation of alkali metals or alkaline earth metals. It can be manufactured by a known technique such as treatment with a substance, or a method similar thereto. The strongly acidic cation exchange resin used in the method of the present invention may be of any type, such as H type, Na type, or NH + 4 type, but it is usually preferable to use H type.
Further, as the base of the ion exchange resin, any type of base such as gel type, porous type, or macroporous type can be used. Therefore, the brand is not particularly limited as long as it is a strongly acidic cation exchange resin. Furthermore, there is no problem in using two or more brands of strongly acidic cation exchange resins together. When using an alkali metal or alkaline earth metal salt of 3-substituted aziridine-2-carboxylic acid as a raw material, the amount of ion exchange resin used is the amount of 3-substituted aziridine-2-carboxylic acid and its salt. 1 equivalent or more based on the exchange capacity in a wet state based on the total amount of metal ions, preferably,
It is 1.2 equivalent or more. For example, when using 1 mol of 3-substituted aziridine-2-carboxylic acid potassium salt as a raw material and using a strongly acidic cation exchange resin with a total exchange capacity of 2 equivalents, the amount of resin used is 1
The above value is preferably 1.2 or more. Also, 3-
When using a substituted aziridine-2-carboxylic acid or a derivative thereof such as an ester, amide, or nitrile, the exchange capacity in a wet state is 1 equivalent or more relative to the 3-substituted aziridine-2-carboxylic acid or its derivative itself. , preferably 1.2 equivalents or more. For example, 1 mole of 3-substituted aziridine-2
- When using a strongly acidic cation exchange resin using carboxylic acid ethyl ester as a raw material and having a total exchange capacity of 2 equivalents, the amount of the resin used is 0.5 or more, preferably 0.6 or more. Inorganic salts such as sodium chloride and ammonium bromide in the aqueous solution of raw materials,
When substances that are easily adsorbed by strongly acidic cation exchange resins, such as compounds containing amino groups, are included, it is necessary to increase the amount of resin by more than the amount corresponding to these substances. In the method of the present invention, the 3-substituted aziridine-2-carboxylic acid represented by the general formula () or its derivative contains an aqueous solution or an organic solvent miscible with water, such as alcohols such as methanol, ethanol, and isopropanol. an aqueous solution of
These aqueous solutions are poured into a resin column filled with a strongly acidic cation exchange resin, and then washed with water, or the strongly acidic cation exchange resin is added to and mixed with these aqueous solutions, so that the ion exchange resin adsorbs them. . In particular, when the aqueous solution of the raw material compound contains a compound such as sodium chloride or ammonium bromide that generates oxygen substances such as hydrochloric acid or hydrobromic acid through ion exchange, the raw material compound may be ionized. Since there is a possibility that the halogen ions may be desorbed from the exchange resin or react with the raw material compound, the raw material aqueous solution is poured into the ion exchange resin tower, and then thoroughly washed with water to remove the 3-substituted aziridine-2-carboxylic acid or its derivative. A method of adsorbing the compound to a strongly acidic cation exchange resin is preferred. In this way, the strongly acidic cation exchange resin adsorbed with 3-substituted aziridine-2-carboxylic acid or its derivative is heated in the presence of water. There are no particular limitations on the heating method, but it is necessary to maintain a moist state, and heated water may be continuously passed through a column filled with ion exchange resin, or a column filled with ion exchange resin may be used. It may be heated externally. Alternatively, the ion exchange resin can be transferred to a separate container and heated while stirring in the presence of water. The heating conditions are 40 to 120°C for 1 to 100 hours, preferably 50 to 100°C for 2 to 50 hours. Although the reaction proceeds at temperatures below 40° C., for example at room temperature, it takes an extremely long time to complete the reaction, which is not practical. The β-substituted-β-hydroxy amino acid produced by heating the 3-substituted aziridine-2-carboxylic acid or derivative adsorbed on the ion exchange resin is adsorbed on the ion exchange resin after the reaction, and this β- Substituted β-hydroxy amino acids can be isolated by elution from an ion exchange resin according to conventional methods.
For example, the adsorbed β-substituted β-hydroxyamino acid is eluted with aqueous ammonia, the eluate is concentrated to dryness, or the eluate is concentrated to below the solubility of the β-substituted β-hydroxyamino acid, and then crystallized. isolated by The method of the present invention will be explained below by way of examples. Note that the 3-substituted aziridine-2-carboxylic acid salts or 3-substituted aziridine-2-carboxylic acid derivatives used as raw materials in Examples 1 to 8 and 10 and 11 are a mixture of cis and trans forms,
The resulting β-hydroxyamino acid is also a mixture of threo and erythro forms. In addition, in the Examples, purity analysis and yield were determined by methods such as high performance liquid chromatography and nuclear magnetic resonance spectroscopy. Example 1 160 ml of an aqueous solution of 12.9 g of 3-methylaziridine-2-carboxylic acid ethyl ester was passed through 60 ml of strongly acidic cation exchange resin Lewatit S-100 (H type) (manufactured by Bayer), and further washed with 60 ml of distilled water. te3
-Methylaziridine-2-carboxylic acid ethyl ester is adsorbed. After that, this ion exchange resin was transferred to a 100ml flask and reacted at 80-85â for 7 hours, then transferred to the column again and 5% ammonia water was added.
eluted with 90 ml and 60 ml of distilled water. This eluate was concentrated to dryness to obtain 11.4 g of threonine. The obtained threonine had a purity of 92.5% and a yield of 88.6%. In addition, as a raw material, 3-methylaziridine-2
- When a mixture of carboxylic acid ethyl ester with a ratio of cis isomer to trans isomer at 66:34 was used, the threonine produced was a mixture of threo isomer and allo isomer at 70:30. Furthermore, when only the cis isomer was used as a raw material, most of the compounds were the threo isomer. Example 2 136 ml of an aqueous solution of 8.2 g of 3-methylaziridine-2-nitrile is passed through 60 ml of Lewatit S-100 (H type) and washed with 60 ml of distilled water to adsorb 3-methylaziridine-2-nitrile. Thereafter, hot water heated to 80 to 85°C is circulated through the ion exchange resin for 8 hours. After the reaction, the ion exchange column was cooled and eluted with 90 ml of 5% aqueous ammonia and 60 ml of distilled water, and the eluate was concentrated to dryness to yield 4.9 g of threonine.
7.6 g of solid containing . The obtained threonine had a purity of 64.5% and a yield of 41.2%. Example 3 To 160 g of an aqueous solution of 15.5 g of α-chloro-β-amino-n-butyronitrile hydrochloride is gradually added dropwise, with stirring, an aqueous solution of 12.8 g of sodium hydroxide dissolved in 90 g of water. The reaction mixture is then heated to 60°C and reacted at 60-65°C for 6 hours. Next, this reaction solution was cooled, neutralized with a 5% aqueous sulfuric acid solution, and passed through a column packed with 400 ml of Lewatit S-100 (H type). Further, distilled water was allowed to flow through the column until no chloride ions were detected in the distillate from the column. Then, the 3-methylaziridine-2-carboxylic acid was adsorbed on an ion exchange column at 85-90°C.
The reaction is carried out by circulating hot water heated to
After the reaction, the ion exchange column was cooled and eluted with 600 ml of 5% aqueous ammonia and 400 ml of distilled water. This eluate was concentrated to dryness to obtain 11.0 g of threonine. The obtained threonine has a purity of 88.7% and a yield of 82%.
It was hot. Example 4 The same reaction as in Example 3 was carried out except that 20.2 g of α-chloro-β-aminobutyric acid ethyl ester hydrochloride was used to obtain 10.5 g of threonine. The obtained threonine had a purity of 93.0% and a yield of 82.0%. Example 5 100 ml of an aqueous solution of 7.2 g of 3-methylaziridine-2-carboxylic acid isopropyl ester was added to Lewatit S
Pass through 30 ml of -100 (H type) and wash with 30 ml of distilled water to adsorb 3-methyl-aziridine-2-carboxylic acid isopropyl ester. after that,
Hot water heated to 80 to 85°C is circulated through this ion exchange resin for 8 hours. After the reaction, the ion exchange column was cooled and eluted with 45 ml of 5% aqueous ammonia and 30 ml of distilled water, and the eluate was concentrated to dryness to yield 11.2 g of threonine.
I got it. The obtained threonine has a purity of 95.9% and a yield of
It was 90.3%. Examples 6 to 8 Strongly acidic cation exchange resin Lewatit S-100
The reaction was carried out in the same manner as in Example 5 except that other resins were used instead, and the results shown in Table 1 were obtained. [Table] Example 9 3,3-dimethylaziridine-2-carboxylic acid
Add 72 ml of 5.8 g aqueous solution to Lewatit S-100 (H type) 30
ml, and then rinse with 30 ml of distilled water.
Adsorb dimethylaziridine-2-carboxylic acid. After that, this ion exchange resin was transferred to a 100ml flask and reacted at 80-85â for 7 hours, then transferred to the column again and mixed with 45ml of 5% ammonia water and 30ml of distilled water.
eluted with ml. This eluate was concentrated to dryness to obtain 6.4 g of β-hydroxyvaline. The β-hydroxyvaline obtained had a purity of 91.3% and a yield of 88.5%. Example 10 150 ml of an aqueous solution containing 10.3 g of 3-phenylaziridine-2-carboxylic acid isopropyl ester
Suitable for Lewatit S-100 (H type) 40ml, distilled water
Wash with 40 ml of water to adsorb 3-phenylaziridine-2-carboxylic acid isopropyl ester. Thereafter, hot water heated to 80 to 85°C is circulated through the ion exchange resin for 8 hours. After the reaction, cool the ion exchange column and add 60ml of 5% ammonia water and 90ml of distilled water.
This eluate was concentrated to dryness to give a product of 9.0 ml.
I got g. The product contained 83.3% phenylserine, and the yield as phenylserine was 82.9%. Example 11 160 ml of an aqueous solution of 8.1 g of 3-phenylaziridine-2-carboxylic acid amide was treated in exactly the same manner as in Example 10 to obtain 8.7 g of product. The product is 56.3
% of phenylserine, and the yield of phenylserine was 54.1%. Example 12 160 ml of an aqueous solution of 10.3 g of 3-(2-pyridyl)aziridine-2-carboxylic acid isopropyl ester
was treated as in Example 10 to give product 9.2
I got g. The product contained 80.4% 2-pyridylserine, and the yield of 2-pyridylserine was 81.3%. Example 13 The same method as in Example 1 was performed, except that 19.1 g of 3-methylaziridine-2-carboxylic acid benzyl ester was used instead of aziridine-2-carboxylic acid methyl ester.
It was carried out using 11.8 g of threonine was obtained. Purity 91.7%,
The yield was 91.3%.
Claims (1)
ã®ããšãã«åºãŸãã¯ããªãžã«åºãR2ã¯æ°ŽçŽ åå
ãŸãã¯ã¡ãã«åºã瀺ããã¯âCO2HãâCO2M
ïŒããã§ãïŒã¯ã¢ã«ã«ãªéå±ãŸãã¯ã¢ã«ã«ãªåé¡
éå±ã§ããïŒãâCO2R3ïŒããã§ãR3ã¯ççŽ åå
æ°ïŒãïŒã®äœçŽã¢ã«ãã«åºãŸãã¯ãã³ãžã«åºã§ã
ãïŒãâCONH2ãŸãã¯âCNã瀺ãïŒã§è¡šããã
ãïŒâ眮æã¢ãžãªãžã³âïŒâã«ã«ãã³é žãŸãã¯ã
ã®èªå°äœãåŒ·é žæ§åã«ããªã³äº€ææš¹èã«åžçãã
ãŠãæ°Žã®ååšäžã§å ç±ããããšãç¹åŸŽãšããβâ
眮æâβâããããã·ã¢ããé žã®è£œé æ³ã[Claims] 1 General formula () (In the formula, R 1 is a methyl group, a substituted or unsubstituted phenyl group, or a pyridyl group, R 2 is a hydrogen atom or a methyl group, and X is -CO 2 H, -CO 2 M
(wherein M is an alkali metal or alkaline earth metal), âCO 2 R 3 (wherein R 3 is a lower alkyl group having 1 to 5 carbon atoms or a benzyl group), âCONH 2 or β-, which is characterized by adsorbing 3-substituted aziridine-2-carboxylic acid represented by -CN) or its derivative on a strongly acidic cation exchange resin and heating it in the presence of water.
Substituted method for producing β-hydroxy amino acids.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7813481A JPS57193432A (en) | 1981-05-25 | 1981-05-25 | Production of beta-hydroxyaminoacid |
AU84520/82A AU550973B2 (en) | 1981-05-19 | 1982-03-19 | Process for preparing b-hydroxy amino acid |
IT21337/82A IT1151414B (en) | 1981-05-19 | 1982-05-18 | PROCESS FOR THE PRODUCTION OF BETA-HYDROXYAMINOACIDS |
KR8202182A KR860001885B1 (en) | 1981-05-19 | 1982-05-19 | A process for preparing beta-hydroxy amino acids |
EP82901531A EP0079390B1 (en) | 1981-05-19 | 1982-05-19 | Process for preparing beta-hydroxy amino acid |
PCT/JP1982/000182 WO1982004044A1 (en) | 1981-05-19 | 1982-05-19 | Process for preparing beta-hydroxy amino acid |
CA000403290A CA1185979A (en) | 1981-05-19 | 1982-05-19 | PRODUCTION PROCESS OF .beta.-HYDROXYAMIDO ACIDS |
MX192763A MX155815A (en) | 1981-05-19 | 1982-05-19 | PROCEDURE FOR PREPARING BETA-HYDROXYAMINO-ACID |
DE8282901531T DE3268091D1 (en) | 1981-05-19 | 1982-05-19 | Process for preparing beta-hydroxy amino acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7813481A JPS57193432A (en) | 1981-05-25 | 1981-05-25 | Production of beta-hydroxyaminoacid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57193432A JPS57193432A (en) | 1982-11-27 |
JPH0134218B2 true JPH0134218B2 (en) | 1989-07-18 |
Family
ID=13653402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7813481A Granted JPS57193432A (en) | 1981-05-19 | 1981-05-25 | Production of beta-hydroxyaminoacid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57193432A (en) |
-
1981
- 1981-05-25 JP JP7813481A patent/JPS57193432A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57193432A (en) | 1982-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2619951B2 (en) | Gabapentin monohydrate and method for producing the same | |
JPS5943459B2 (en) | N-alkylpiperidine derivative | |
JPS5921684A (en) | 3-aminoquinuclidine derivatives, manufacture and therapeutical drug | |
JPH0245624B2 (en) | ||
JPH02231457A (en) | Method for synthesizing l-(-)-2-amino-3-(3,4- dihydroxyphenyl)propanoic acid, product thereby, and use of said product in said synthesis | |
JPH0219820B2 (en) | ||
US5565185A (en) | Process for the preparation of radiolabeled meta-halobenzylguanidine | |
JPH0134218B2 (en) | ||
JP2001048864A (en) | COMPOUND FOR PRODUCING beta-ADRENALINE RECEPTOR ANTAGONIST AND METHOD | |
KR860001885B1 (en) | A process for preparing beta-hydroxy amino acids | |
JPS5936626B2 (en) | Method for producing 1H-indazole acetic acid derivative | |
US4366317A (en) | Process for synthesis of N-(hydrocarbyl)substituted-p-menthane-3-carboxamide | |
Stammer et al. | Synthesis of racemic threo-and erythro-. beta.-hydroxylysines | |
JPH0134217B2 (en) | ||
JPS59137465A (en) | Manufacture of imidazole-4,5-dicarboxylic acid | |
SU666169A1 (en) | Method of obtaining dl-lysine | |
JP2767295B2 (en) | Method for producing indole-3-carbonitrile compound | |
JPS5993059A (en) | Preparation of cytosines | |
JPH01131143A (en) | Optical resolution of d,l-carnitinenitrile chloride | |
Taguchi et al. | Stereochemistry of the 2, 2'-Dihydroxydicyclohexylamines. I1 | |
JP2607896B2 (en) | Method for producing isotope-labeled 3,4: 5,6-di-O-isopropylidene-D-glucononitrile | |
JPS6258347B2 (en) | ||
JPS5921674A (en) | Manufacture of pure water-free imido acid ester by reaction of nitrile and aminoalcohol | |
JPS6261584B2 (en) | ||
JP5319339B2 (en) | Method for producing aliphatic nitrile |